2023
DOI: 10.1016/j.hermed.2023.100631
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Berberis vulgaris fruit powder on visfatin and metabolic profiles in type 2 diabetes mellitus patients: A randomized, double-blind, placebo-controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…97 Another intervention involving Berberis vulgaris fruit for 8 weeks also decreased FBG. 98 Additionally, based on an RCT, it was shown that Morinda citrifolia fruit juice decreased FBG, HbA1c, and high sensitivity C-reactive protein (hs-CRP), and increased C-peptide in 20 T2D patients undergoing standard treatment, indicating that it could ameliorate diabetes by promoting insulin excretion and alleviating inflammation. 99 Another RCT of 89 T2D patients showed that a 120-day intervention using turmeric reduced FBG, HbA1c, homeostatic model assessment of insulin resistance (HOMA IR), and serum triglyceride, while the yellow passion fruit only decreased FBG and HbA1c.…”
Section: Clinical Trialsmentioning
confidence: 99%
“…97 Another intervention involving Berberis vulgaris fruit for 8 weeks also decreased FBG. 98 Additionally, based on an RCT, it was shown that Morinda citrifolia fruit juice decreased FBG, HbA1c, and high sensitivity C-reactive protein (hs-CRP), and increased C-peptide in 20 T2D patients undergoing standard treatment, indicating that it could ameliorate diabetes by promoting insulin excretion and alleviating inflammation. 99 Another RCT of 89 T2D patients showed that a 120-day intervention using turmeric reduced FBG, HbA1c, homeostatic model assessment of insulin resistance (HOMA IR), and serum triglyceride, while the yellow passion fruit only decreased FBG and HbA1c.…”
Section: Clinical Trialsmentioning
confidence: 99%